ABSTRACT: Toads in the genus Bufo are commonly kept in pet, research, and zoological settings and may require anesthesia during veterinary care. Limited information is available comparing anesthetic protocols in most amphibian species. The purpose of this study was to evaluate the clinical and cardiopulmonary effects of tricaine methanesulfonate (MS-222) and propofol in Sonoran desert toads (Bufo alvarius). Nine juvenile Sonoran desert toads were anesthetized with an immersion bath of 1 g/L MS-222 and 35 mg/kg intracoelomic propofol with a minimum 2-wk wash-out period between trials. Heart rate, respiratory rate, and reflexes (righting, escape, corneal, superficial pain, and deep pain) were monitored every 5 min for the first 90 min and then every 10 min for the next 90 min during both anesthetic trials. Surgical anesthesia was defined as complete loss of all measured reflexes. MS-222 produced surgical anesthesia in 100% (9/9) of toads, whereas propofol produced surgical anesthesia in 11.1% (1/9). Mean induction time for the MS-222 trial was 19.9 min (SD: 5.4, Min-Max: 13-30), with mean duration of surgical anesthesia 23.9 min (SD: 10.8, Min-Max: 10-42). Mean recovery time after removal from the MS-222 bath was 85.3 min (SD: 18.5, Min-Max: 60-110). Righting reflex was lost in all animals in the propofol trial at a mean of 23.9 min (SD: 5.5, Min-Max: 20-35) following administration. A single animal in the propofol trial reached a surgical plane of anesthesia at 25 min post-administration, with surgical anesthesia lasting for 50 min. Mean time to recovery following administration of propofol was 145 min (SD: 47.2, Min-Max: 60-180); one toad was not fully recovered at the end of the monitoring period. Heart rate was not found to significantly (P > 0.05) change from baseline at any monitoring point for either anesthetic protocol. Respiratory rate was found to decrease significantly (P < 0.05) at all time points between 5 and 65 min in the MS-222 trial and between 10 and 130 min in the propofol trial. MS-222 at 1 g/L immersion was found to reliably produce surgical anesthesia in Sonoran desert toads with a faster onset of action and recovery when compared to propofol administered intracoelomically at 35 mg/kg.
INTRODUCTION
The ability to safely and reliably anesthetize amphibian patients is essential when immobilization is required for surgical or other invasive procedures. Anesthetic agents and routes used in amphibian anesthesia include immersion baths with tricaine methanesulfonate (MS-222) or clove oil, topical application of benzocaine or isoflurane, parenteral administration of propofol or other injectable anesthetics, and inhalation anesthesia with isoflurane or other anesthetic gases (Wright, 2001; Mitchell, 2009) .
Toads in the genus Bufo are commonly kept in both companion animal and research settings and are used as exhibit and educational animals at zoological institutions. Despite the wide use of animals in this genus, there are few published studies evaluating the effects of anesthesia in Bufo toads. The available studies often focus on specific physiologic changes in a research setting and are not clinical anesthetic trials or comparisons (Middler et al., 1968; Smith, 1974; Stetter et al., 1996; Andersen and Wang, 2002; Coelho and Smatresk, 2003) . Extrapolation from anesthetic trials in other anuran species may not be accurate because the majority of studies have been performed with immersion or topical anesthetics using aquatic anurans, which have thinner skin that is potentially more permeable to anesthetic agents (Lafortune et al., 2001; Cakir, 2005; Guenette et al., 2007; Ardente et al., 2008) .
MS-222 is a water-soluble benzocaine derivative that is commonly administered in bath form, although parenteral use has also been reported (Letcher, 1992; Wright, 2001; Mitchell, 2009) . MS-222 is acidic in solution (pH 3.0), and buffering with addition of sodium bicarbonate at a 1:1 ratio of dry weight is recommended but has not always historically been employed (Wright, 2001; Stetter, 2007; Mitchell, 2009) . Recommended doses range from 0.2 g/L to 5.0 g/L depending on life-stage (larval vs. adult), natural history (aquatic vs. terrestrial), and size (Wright, 2001; Stetter, 2007; Mitchell, 2009 ). Toad species have been reported to require concentrations on the higher end of the range because of thicker integument; however, use of a buffered solution may result in similar results with lower concentrations because solutions with a physiologically neutral pH maintain tricaine in an un-ionized form, which improves absorption and enhances its anesthetic effects (Wright, 2001; Mitchell, 2009) .
Propofol is a short-acting nonbarbiturate anesthetic commonly used for induction and, in some cases, maintenance of anesthesia in mammals, birds, and reptiles. It is most often administered via intravenous or intraosseous injection; however, intracoelomic injection and immersion techniques have also been described in amphibians (Von Esse and Wright, 1999; Guenette et al., 2008; Mitchell, 2009; Mitchell et al., 2009) . Cardiopulmonary depression was the only adverse effect reported in a study involving tiger salamanders (Ambystoma tigrinum), and surgical anesthesia was reached in the majority of animals administered an intracoelomic dose of 35 mg/kg of propofol . Death was observed at higher doses both in White's tree frogs (Pelodryas caerulea) with intracoelomic administration, and African clawed frogs (Xenopus laevis) immersed in a propofol bath (Von Esse and Wright, 1999; Guenette et al., 2008) .
The purpose of this study was to evaluate the clinical and cardiopulmonary effects of MS-222 and propofol as anesthetic agents in Sonoran desert toads. It was hypothesized that both MS-222 administered via immersion and propofol administered intracoelomically would produce surgical anesthesia and that bradypnea and bradycardia would occur with both anesthetic protocols.
MATERIALS AND METHODS
Study animals consisted of nine juvenile, captive-born, Sonoran desert toads (Bufo alvarius) of unknown sex weighing 55.8-190.2 g. Toads were housed in a quarantine setting at a zoological institution for at least two months prior to the study. The study was approved by the Chicago Zoological Society Institutional Animal Care and Use Committee. Toads were randomly assigned to three groups of three animals each and were housed in 122 cm × 53 cm plastic cages with sliding glass front (Standard 48-inch Reptile Cage, Neodesha Plastics Inc., Neodesha, KS) and clay hide boxes. Enclosure temperatures ranged from 22.2-30.6°C (72-87°F), and substrate consisted of brown paper and damp sphagnum moss. Fresh dechlorinated water was provided in shallow bowls, and enclosures were frequently misted with dechlorinated water to maintain damp substrate. Toads were fed crickets (Acheta domestica) once daily or every other day; crickets were dusted with calcium powder (Calcium with vitamin D 3 ultrafine powder, Rep-Cal Research Labs, Los Gatos, CA) and a powdered vitamin supplement (Nekton-Rep, Günter Enderle, Pforzheim, Germany) once weekly and gut-loaded with commercial insect diets (Fluker's Orange Cube Complete Cricket Diet, Fluker Farms, Port Allen, LA and Ortho Cal Insect Supplement, Marion Zoological Inc. Plymouth, MN) prior to feeding.
All toads had arrived from a previous institution with radiographic evidence of bony deformities, and a few had visible, mild scoliosis consistent with nutritional deficiencies at an early age. All animals were otherwise healthy based on physical examination, fecal parasite analysis, and observation of normal behavior and appetite following entry into quarantine.
Using a cross-over design, each toad underwent a series of two anesthetic protocols, with a minimum 2-wk wash-out period between trials. The first anesthetic protocol consisted of an immersion bath of 1 g/L of MS-222 (Tricaine-S, Western Chemical Inc. Ferndale, WA) buffered with 1g/L sodium bicarbonate (S233-500, Fischer Scientific, Fair lawn, NJ). The second protocol consisted of intracoelomic administration of propofol (PropoFlo, Abbott Animal Health, Abbott Park, IL) at a dose of 35 mg/kg. Toads were weighed prior to each trial, and a brief physical examination was performed. Trials were performed at 22-23°C (72-74°F), with the toads contained in clear plastic containers lacking substrate.
Prior to initiation of each trial, baseline heart rate (measured by Doppler probe placed over the ventral pectoral girdle) and respiratory rate (measured by observation of gular movement) of each individual was obtained. Baseline reflexes (escape, righting, corneal, superficial pain, deep pain) were also evaluated prior to anesthesia. The escape reflex was evaluated by placing the toad in an open hand and measuring its ability to move away from a stimulus. The righting reflex was evaluated by placing the animal in dorsal recumbency and monitoring its ability to right itself to normal posture. The corneal reflex was evaluated by gentle application of a moist cotton-tip applicator to the corneal surface and assessment of the blink response. Superficial pain was assessed via response to a skin pinch of the caudal thigh with hemostats that had been modified with cut red rubber tubing to soften the tips. Deep pain was assessed as the response to pinching of the digits on the rear limbs with the modified hemostats. Each reflex was assigned an ordinal rank of 1-3: 1) reflex present, 2) reflex slowed, 3) reflex absent. Toads were determined to have reached a surgical anesthetic plane when all reflexes were absent. Induction time was defined as the period following immersion or injection of anesthetic until the time a surgical anesthetic plane was reached. Animals were considered to be recovered when all reflexes had returned to baseline values.
Following measurement of baseline physiological parameters and reflexes, each toad in the first trial was placed in an individual bath of buffered MS-222. MS-222 was prepared via addition of 1 g of MS-222 and 1 g of sodium bicarbonate to one liter of de-ionized water followed by agitation. Bath depth was 2-3 cm, ensuring full immersion of the ventral body of each toad. The plastic containers were tilted, and the toads' heads were slightly raised on moistened gauze squares as necessary to maintain the nares of the toad above the bath as anesthetic depth deepened. Heart rate, respiratory rate, and reflexes were measured every 5 min for the first 90 min and then every 10 min for an additional 90 min. When a surgical plane of anesthesia was reached, toads were removed from the bath, thoroughly rinsed with de-ionized water, and returned to clean empty containers for further monitoring. In the second trial, identical baseline measurements were obtained, and the toads were injected with 35 mg/kg propofol intracoelomically into the caudal coelomic cavity. Following propofol injection, toads were monitored using the same techniques and intervals as previously described. In both trials, after 180 min, the toads were returned to their original enclosures and monitoring was ceased.
escape reflex (P = 0.0001), righting reflex (P = 0.001), corneal reflex (P = 0.0001), superficial pain (P = 0.0001), and deep pain (P = 0.0001) in toads anesthetized with propofol over time. Escape reflex was found to significantly decrease during examinations conducted between 10 and 150 min postanesthetic induction (all P < 0.05). Righting reflex was found to significantly decrease during examinations conducted between 10 and 110 min postanesthetic induction (all P < 0.05). The average time to the loss of the righting reflex was 23.9 min (SD: 5.5, Min-Max: 20-35). Corneal reflex was found to significantly decrease (all P < 0.05) between 15 and 40 min post-propofol. Toads were significantly (all P < 0.05) less likely to respond to superficial pain or deep pain stimulation 25-110 and 25-70 min post-propofol, respectively. Only one (11.1%) toad lost all of its reflexes (25 min) and achieved surgical anesthesia (duration 50 min). The average time to recovery for the eight toads that recovered before the last examination (180 min)
The distribution of the data was evaluated using the Shapiro-Wilk test. Continuous data that were normally distributed were reported by the mean, standard deviation (SD), and minimum-maximum (Min-Max), whereas nonnormally distributed data were reported by the median, 10-90%, and Min-Max. A general linear model for repeated measures was used to determine whether there was a difference in normally distributed continuous data (HR and RR) over time. If a significant difference was found, paired t-tests were used to determine at what time points the difference occurred from Time 0. A Friedman's test for repeated measures was used to determine whether there was a difference in ordinal data (reflexes) or nonnormally distributed continuous data over time. If a significant difference was found, Wilcoxon signed-rank tests were used to determine at what time points the difference occurred from Time 0. A P ≤ 0.05 was used to determine statistical significance. A power analysis was performed when the alpha was 0.06-0.10 to assess for the potential of a Type II error. SPSS 18.0 (SPSS Inc., Chicago, IL) was used to analyze the data.
RESULTS

MS-222:
The average weight of the toads used for the MS-222 study was 118.9 g (SD: 44.9, Min-Max: 64.8-190.2). The average induction time for MS-222 was 19.9 min (SD: 5.4, Min-Max: 13-30). There was a significant difference in respiratory rate (P = 0.0001) over time for toads anesthetized with MS-222. Respiratory rate was found to significantly decrease during examinations conducted between 5 and 65 min postanesthetic induction (all P < 0.05). Apnea was observed in 77.8% of toads (7/9) anesthetized with MS-222. Average duration of apnea was 16.4 min (SD: 13.4, Min-Max: 5-40). There was no significant difference (P = 0.6) in heart rate over time for toads anesthetized with MS-222. There were significant differences in the escape reflex (P = 0.0001), righting reflex (P = 0.001), corneal reflex (P = 0.0001), superficial pain (P = 0.0001), and deep pain (P = 0.0001) in toads anesthetized with MS-222 over time. Escape reflex was found to significantly decrease during examinations conducted between 10 and 95 min postanesthetic induction (all P < 0.05). Righting reflex was found to significantly decrease during examinations conducted between 10 and 80 min postanesthetic induction (all P < 0.05). Corneal reflex was found to significantly decrease (all P < 0.05) between 10 and 70 min post-MS-222. Toads were significantly (all P < 0.05) less likely to respond to superficial pain or deep pain stimulation 5-100 and 10-65 min post-MS-222, respectively. The average duration of surgical anesthesia for toads anesthetized with MS-222 was 23.9 min (SD: 10.8, Min-Max: 10-42). The average time to recovery for the toads was 85.3 min (SD: 18.5, Min-Max: 60-110). Results are summarized in Tables 1 and 2 .
Propofol:
The average weight of the toads used for the propofol study was 118.9 g (SD: 46.4, Min-Max: 55.8-182.1). There was a significant difference in respiratory rate (P = 0.0001) over time for toads anesthetized with propofol. Respiratory rate was found to significantly decrease during examinations conducted between 10 and 130 min postanesthetic induction (all P < 0.05). There was no significant difference (P = 0.3) in heart rate over time for toads anesthetized with propofol. There were significant differences in the was 145 min (SD: 47.2, Min-Max: 60-180). One toad did not recover by 180 min but had fully recovered prior to the next evaluation 24 h later. Results are summarized in Tables 1 and 2 .
DISCUSSION
Anesthesia with MS-222 (1 g/L buffered with sodium bicarbonate) in Sonoran desert toads resulted in reliable induction of surgical anesthesia in all toads with an average induction time of 19.9 min. In contrast, only one toad (11.1%) in the propofol group reached a surgical plane of anesthesia, although all toads lost both escape and righting reflexes. Mean duration of surgical anesthesia in the MS-222 trial was 23.9 min, in contrast to 50 min duration in the single animal reaching a surgical plane with intracoelomic propofol. A more rapid mean recovery time was also observed in the MS-222 trial in comparison to the propofol trial (83.5 vs. 145 min). Although both superficial and deep pain sensation were assessed at all intervals in this study as part of the assessment of anesthetic depth, toads showing response to superficial pain should also be responsive to deep pain. Therefore, the response to deep pain stimulation may be omitted if animals show a positive response to the superficial pain stimulus. Cutaneous absorption of MS-222 in this species was considered effective at the 1 mg/L immersion concentration, despite previous reports of Bufo species requiring doses up to 3 mg/L because of thicker integument than more aquatic anurans (Crawshaw, 1993) . Buffering of the solution with an equal dry weight of sodium bicarbonate results in the majority of tricaine molecules in the un-ionized form and, thus, available for absorption, which may account for the discrepancy with some previous reports (Wright, 2001; Mitchell, 2009 ). The MS-222 solution in this study was buffered with a clinically recommended dose of sodium bicarbonate (equal dry weight of MS-222), which was presumed to buffer the solution to a neutral pH (7.0-7.5); however, ideally the pH of the anesthetic solution should be measured prior to patient immersion to ensure adequate buffering (Wright, 2001; Mitchell, 2009) . Sonoran desert toads did require a higher concentration of MS-222 in comparison to a study in leopard frogs (Rana pipiens), in which a concentration of 0.2 g/L MS-222 was recommended to produce similar induction and recovery times for a surgical plane of anesthesia (Cakir and Strauch, 2005) . Although not evaluated in this study, the period of surgical anesthesia produced by MS-222 sedation can be extended for longer procedures by re-immersion in a less concentrated bath (50% of initial concentration) or by intermittent application of small aliquots of the original solution (Wright, 2001; Mitchell, 2009) .
The dose of propofol selected for this study was based on a previous investigation in tiger salamanders, which evaluated the effects of two dosages (25 mg/kg and 35 mg/kg) of propofol administered intracoelomically ). In the salamander study, 83% of animals reached a surgical plane of anesthesia with the 35-mg/kg dose, in contrast to the current study where only one animal (11%) reached a surgical plane. Initial investigation of intracoelomic propofol has also been performed in White's tree frogs, with dosages of 9.5 mg/kg, 30 mg/kg, and 53 mg/kg producing moderate anesthesia, surgical anesthesia, and death, respectively (Von Esse and Wright, 1999) . Species differences in the speed and efficacy of propofol absorption across coelomic membranes, or differences in protein binding or receptor affinity, may explain these discrepancies in response, and further investigation of different doses and effects in additional species is indicated. No toad in this study exhibited any signs suggestive of coelomic irritation following administration of propofol, which was expected given the lack of previous adverse reports following intracoelomic injection in other species and that inadvertent extravascular injection in domestic dogs and cats has not been associated with tissue irritation (Plumb, 2008; Mitchell et al., 2009) . Although the intracoelomic route of administration was selected for this study, intravenous and intraosseous administration of propofol has been reported in amphibians (Mitchell, 2009) . Injection into the dorsal lymph sac may be an alternate site of administration in amphibian patients, although further investigation would be required to determine efficacy and safety of this technique.
Both anesthetic protocols resulted in significant bradypnea, with the propofol group having a longer period of respiratory depression than the MS-222 group (during evaluations conducted between 10 and 130 and 5 and 65 min, respectively). Despite the shorter period of respiratory depression in the MS-222 trial, periods of apnea were observed in most toads (77.8%) anesthetized with MS-222 but in none of the toads in the propofol trial. In contrast, most salamanders administered propofol at the same dose in a previous study showed variable periods of apnea . No significant alterations of heart rate were found in either anesthetic group, although a previous study evaluating cardiac stimulation under MS-222 anesthesia in marine toads (Bufo marinus) showed a significant rise in heart rate because of sympathetic stimulation (Smith, 1974) .
Ventilatory depression and apnea have been reported in multiple amphibian species when using a variety of anesthetic protocols (Lafortune et al., 2001; Wright, 2001; Andersen and Wang, 2002; Stetter, 2007; Mitchell, 2009; Mitchell et al., 2009) . Because amphibians use multiple methods for respiratory exchange (pulmonary, buccopharyngeal, and cutaneous), apnea is less of a concern than in other vertebrate groups, although hypoxia and respiratory acidosis have been reported in several amphibian species (including Bufo toads) during periods of apnea (Wright, 2001; Andersen and Wang, 2002; Coelho and Smatresk, 2003) . Amphibians are thought to be more tolerant of hypoxia and associated metabolic disturbances than are mammals because of adaptations for aestivation and dormancy in some species (Bickler and Buck, 2007) . Supplemental oxygen was not provided in this study, because animals were removed from the anesthetic solution as soon as a surgical anesthetic plane was reached. Both hypoxemia and hypercapnia have been shown to drive amphibian respiration, and room air is recommended for anesthetic recovery to encourage normal respiration (Wright, 2001) . In clinical practice, supplementation of oxygen (via bubbling through the anesthetic solution, endotracheal tube, or oxygen flow across the skin) may be used during prolonged procedures or if signs of hypoxia are observed (Wright, 2001) . In this study, all toads recovered normally, and none showed long-term complications from bradypnea or the transitory apnea observed in most animals during the MS-222 trial. Further investigation of the effects of bradypnea and apnea on this species using pulse oximetry and blood gas analysis is recommended; however, this was beyond the scope of the present study.
A previous study evaluating MS-222 and benzocaine in Fowler's toads (Bufo fowleri) showed unexpected mortality, with 35% mortality using a 1 g/L solution of benzocaine and 12% mortality using a 0.5 g/L unbuffered solution of MS-222 (Cecala et al., 2007) . The high mortality in the previous study was attributed to behavioral and physiological responses to handling stress, because toads were wild caught and had been held less than a week in captivity. The toads were reported to urinate frequently during handling and may have more rapidly absorbed water (and anesthetic) through the pelvic patch to replace fluid loss (Cecala et al., 2007) . No mortality was seen in the current study or previous studies involving anesthesia of Bufo toads with MS-222, despite the use of at least twice the concentration of the Fowler's toad study (Middler et al., 1968; Smith, 1974) . The toads in the current study were captive-bred animals that were likely acclimated to handling and captive housing; however, species differences in response to anesthetic agents and differences in anesthetic protocol may also play a role.
The results of this study support the conclusion that MS-222 at 1 g/L buffered with sodium bicarbonate is a safe and effective anesthetic for Sonoran desert toads and possibly other Bufo species. This protocol produced reliable surgical anesthesia after a mean immersion time of 19.9 min, with a mean duration of surgical anesthesia lasting 23.9 min. Propofol administered intracoelomically at 35 mg/kg did not produce a plane of surgical anesthesia in most of the study toads; however, deep sedation was obtained (with loss of righting reflex) after 23.9 min with no adverse effects, although time to full recovery was longer than with MS-222 anesthesia. Continued investigation and comparison of these and other anesthetic agents in amphibians is recommended to allow veterinarians to make informed decisions regarding the clinical use of anesthetics in amphibian patients.
